406 related articles for article (PubMed ID: 17510096)
21. Treatment of membranous lupus nephritis.
Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
[TBL] [Abstract][Full Text] [Related]
22. Treatment and renal outcome of lupus nephritis: single center experience.
Go KW; Teo SM
Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
[TBL] [Abstract][Full Text] [Related]
24. [Long term survival of patients with lupus nephritis].
Mitić I; Ilić T; Strazmester-Majstorović G; Spasić D; Celić D; Kurjacki B; Stajnic S; Budakov P; Vodopivec S; Sakac V; Djurdjević-Mirković T; Petrović L; Curić S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():32-7. PubMed ID: 12583311
[TBL] [Abstract][Full Text] [Related]
25. Rituximab monotherapy for remission induction of proliferative lupus nephritis flares: description of 3 cases.
Moroni G; Gallelli B; Banfi G; Leoni A; Messa P
J Nephrol; 2010; 23(3):357-61. PubMed ID: 20383866
[TBL] [Abstract][Full Text] [Related]
26. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
27. Clinical status of patients after 10 years of lupus nephritis.
Moroni G; Banfi G; Ponticelli C
Q J Med; 1992 Sep; 84(305):681-9. PubMed ID: 1480742
[TBL] [Abstract][Full Text] [Related]
28. [Long-term outcome of paediatric lupus nephritis].
Casado Picón R; Lumbreras Fernández J; Muley Alonso R; Vara Martín J
An Pediatr (Barc); 2010 May; 72(5):317-23. PubMed ID: 20392678
[TBL] [Abstract][Full Text] [Related]
29. [Lupus nephritis in childhood: clinical and evolutive study of 14 cases].
Chemli J; Krid S; Boussetta S; Abroug S; Ben Dhia N; Ghedira I; Sfar MT; Essoussi AS; Harbi A
Tunis Med; 2007 Aug; 85(8):644-50. PubMed ID: 18254284
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of patients with biopsy-proven lupus nephritis in NUH.
Gan HC; Hyoon K; Fong KY
Singapore Med J; 2002 Dec; 43(12):614-6. PubMed ID: 12693764
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome.
Imbasciati E; Tincani A; Gregorini G; Doria A; Moroni G; Cabiddu G; Marcelli D
Nephrol Dial Transplant; 2009 Feb; 24(2):519-25. PubMed ID: 18565977
[TBL] [Abstract][Full Text] [Related]
32. Renal flare prediction and prognosis in lupus nephritis Hispanic patients.
Mejía-Vilet JM; Córdova-Sánchez BM; Arreola-Guerra JM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
Lupus; 2016 Mar; 25(3):315-24. PubMed ID: 26405028
[TBL] [Abstract][Full Text] [Related]
33. The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) study estimated glomerular filtration rate.
Patel SB; Korbet SM; Lewis EJ
Lupus; 2011 Mar; 20(3):256-64. PubMed ID: 21138981
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of lupus nephritis associated with end-stage renal disease].
Banfi G; Leoni A; Moroni G
G Ital Nefrol; 2008; 25 Suppl 44():S68-S75. PubMed ID: 19048589
[TBL] [Abstract][Full Text] [Related]
36. Long-term prognosis of diffuse lupus nephritis.
Ponticelli C; Zucchelli P; Moroni G; Cagnoli L; Banfi G; Pasquali S
Clin Nephrol; 1987 Dec; 28(6):263-71. PubMed ID: 3327639
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Takada K; Arefayene M; Desta Z; Yarboro CH; Boumpas DT; Balow JE; Flockhart DA; Illei GG
Arthritis Rheum; 2004 Jul; 50(7):2202-10. PubMed ID: 15248218
[TBL] [Abstract][Full Text] [Related]
38. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
[TBL] [Abstract][Full Text] [Related]
39. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
[TBL] [Abstract][Full Text] [Related]
40. Intravenous cyclophosphamide for lupus nephritis in Thai children.
Vachvanichsanong P; Dissaneewate P; Winn T
Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
